Cytotoxic effects of histone deacetylase inhibitor FK228 (depsipeptide, formally named FR901228) in combination with conventional anti-leukemia/lymphoma agents against human leukemia/lymphoma cell lines-Reference-Cited by-同舟云学术

Cytotoxic effects of histone deacetylase inhibitor FK228 (depsipeptide, formally named FR901228) in combination with conventional anti-leukemia/lymphoma agents against human leukemia/lymphoma cell lines

Published:2006-07-22 Issue:1 Volume:25 Page:31-40
ISSN:0167-6997
Container-title:Investigational New Drugs
language:en
Short-container-title:Invest New Drugs

Author:

Kano Yasuhiko,Akutsu Miyuki,Tsunoda Saburo,Izumi Tohru,Kobayashi Hiroyuki,Mano Hiroyuki,Furukawa Yusuke

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10637-006-9000-0.pdf

Reference35 articles.

1. Wolffe AP (1996) Histone deacetylase: a regulator of transcription. Science 272:371–372

2. Kouzarides T (1999) Histone acetylases and deacetylases in cell proliferation. Curr Opin Genet 9:40–48

3. Marks PA, Richon VM, Rifkind RA (2000) Histone deacetylase inhibitors: inducers of differentiation or apoptosis of transformed cells. J Natl Cancer Inst 92:1210–1216

4. Kramer OH, Gottlicher M, Heinzel T (2001) Histone deacetylase as a therapeutic target. Trends Endocrin Met 12:294–300

5. Ueda H, Nakajima H, Hori Y, Fujita T, Nishimura M, Goto T, Okuhara M (1994) FR901228 a novel antitumor bicyclic depsipeptide produced by Chromobacterium violaceum No 968 I Taxonomy fermentation isolation physico-chemical and biological properties and antitumor activity. J Antibiot 47:301–310

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New synergistic combination therapy approaches with HDAC inhibitor quisinostat, cisplatin or PARP inhibitor talazoparib for urothelial carcinoma;Journal of Cellular and Molecular Medicine;2024-05

2. Recent advancement of HDAC inhibitors against breast cancer;Medical Oncology;2023-06-09

3. Clinical Significance of the Histone Deacetylase 2 (HDAC-2) Expression in Human Breast Cancer;Journal of Personalized Medicine;2022-10-08

4. Lapachol acetylglycosylation enhances its cytotoxic and pro-apoptotic activities in HL60 cells;Toxicology in Vitro;2020-06

5. Zinc Dependent Histone Deacetylase Inhibitors in Cancer Therapeutics: Recent Update;Current Medicinal Chemistry;2020-01-03